After seven decades of scientific debate and clinical ambiguity, the International Diabetes Federation (IDF) has officially recognized a fifth form of diabetes in 2025. This landmark decision marks a turning point for a condition that has long existed in the shadows of medical science, often misdiagnosed or entirely overlooked.
The Long Road to Recognition
The history of this condition is one of scientific “vanishing acts.” First described in Jamaica in 1955, the disease was acknowledged by the World Health Organization (WHO) in the 1980s, only to have its classification withdrawn in 1999 due to a perceived lack of evidence.
For years, the medical community struggled to categorize it. However, recent research has clarified why this distinction is vital. Unlike the well-known types of diabetes, this fifth variant—now termed Type 5 diabetes —is fundamentally different in its origin and biological behavior:
- Type 1: An autoimmune condition where the pancreas stops producing insulin.
- Type 2: Characterized by insulin resistance, often linked to lifestyle and diet.
- Type 3c: Resulting from direct damage to the pancreas.
- Gestational: Triggered by hormonal shifts during pregnancy.
- Type 5: Stemming from chronic nutrient deficiency and malnutrition.
Why This Matters: The Danger of Misdiagnosis
The recognition of Type 5 diabetes is not merely a matter of semantics; it is a matter of life and death. Because Type 5 is driven by malnutrition rather than insulin resistance, standard treatments for Type 2 diabetes can be ineffective or even dangerous.
“Understanding the specific types of diabetes someone has is crucial to providing the right treatment,” explains Craig Beall, a diabetes researcher at the University of Exeter.
The biological profile of Type 5 is unique. Research, including studies led by endocrinologist Meredith Hawkins, suggests that patients with this form are insulin-deficient (similar to Type 1) but remain sensitive to insulin (unlike Type 2).
The primary risks include:
– Hypoglycemia: Inappropriate insulin dosages can cause blood sugar to plummet dangerously low.
– Treatment Failure: Using treatments designed for insulin resistance does not address the underlying pancreatic damage caused by nutritional insufficiency.
– Resource Scarcity: In the regions where this is most prevalent, affordable glucose monitoring is often unavailable, making the management of blood sugar spikes or drops even more perilous.
A Global Health Crisis in Disguise
Type 5 diabetes is a disease of inequality. It disproportionately affects populations in Asia, Africa, and parts of Latin America and the Caribbean, where food insecurity is high.
Meredith Hawkins notes that malnutrition-related diabetes is as common as HIV/AIDS and more prevalent than tuberculosis in certain regions. Yet, without a formal name, the medical community has struggled to secure the funding and research necessary to combat it. The lack of a “label” meant there was no way to track prevalence, develop standardized diagnostic criteria, or train healthcare workers to recognize the symptoms.
The Path Forward
With the IDF’s formal recognition, a new specialized working group—chaired by Hawkins—has been established to:
1. Develop formal diagnostic criteria and therapeutic guidelines.
2. Create a global research registry to track the disease’s impact.
3. Train healthcare professionals to identify and treat the condition correctly.
While some scientists remain cautious about the “diagnostic uncertainty” surrounding malnutrition-related cases, the momentum is shifting toward proactive management.
Conclusion: The formal classification of Type 5 diabetes provides a vital framework for addressing a neglected global health crisis, ensuring that millions living with malnutrition-related metabolic issues receive targeted, safe, and effective care.
